Cryofocus Medtech (Shanghai) Co., Ltd.

Research Cryofocus Medtech (Shanghai) Co., Ltd. (6922.HK) on Bullrun: market cap HKD 721.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 721.88M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 95.27M-CNY 38.17M-CNY 6.59M67.2%n/aCNY 35.03MCNY 26.20MCNY 49.74M
FY2024CNY 53.53M-CNY 104.37M-CNY 84.79M71.8%-0.44CNY 45.46MCNY 43.32MCNY 73.85M
FY2023CNY 40.95M-CNY 97.49M-CNY 111.00M75.8%-0.41CNY 103.40MCNY 11.01MCNY 161.47M
FY2022CNY 27.15M-CNY 112.22M-CNY 103.95M71.3%-0.49CNY 226.42MCNY 11.37MCNY 239.13M
FY2021n/an/an/an/a-0.43n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 721.88Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Cryofocus Medtech (Shanghai) Co., Ltd.

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research, development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Cryofocus Medtech (Shanghai) Co., Ltd.'s market cap?

Cryofocus Medtech (Shanghai) Co., Ltd.'s market capitalization is HKD 721.88M.

What does Cryofocus Medtech (Shanghai) Co., Ltd. do?

Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research, development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People's Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases.